Valtruis, Oak HC/FT Partners LLC, HLM Venture Partners and Founders of Rubicon agreed to acquire an unknown majority stake in U.S. Medical Management, LLC from Centene Corporation (NYSE:CNC) on November 3, 2021. Centene will retain a minority stake in USMM. The transaction is subject to clearance under the Hart-Scott Rodino Act and satisfaction of other customary closing conditions. Evercore acted as financial advisor to Centene, and Skadden, Arps, Slate, Meagher & Flom LLP and Locke Lord LLP acted as legal advisor to Centene. Ropes & Gray LLP acted as legal advisor to WCAS. Centene intends to use the proceeds from the sale to repurchase stock. Valtruis, Oak HC/FT Partners LLC, HLM Venture Partners and Founders of Rubicon completed the acquisition of an unknown majority stake in U.S. Medical Management, LLC from Centene Corporation (NYSE:CNC) on December 7, 2021.